Hansa Biopharma appoints Achim Kaufhold as CMO to support the expansion outside transplantation
Hansa Biopharma appoints Professor Achim Kaufhold, M.D., a highly experienced senior leader in immunology, infectious diseases and oncology, as Chief Medical Officer. Achim Kaufhold joins the company on June 1st and will be a Member of the Executive Committee. He will support the Company´s expansion outside transplantation and report to Søren Tulstrup, President and CEO.Lund May 29, 2020. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company has appointed Professor Achim Kaufhold, a very seasoned senior